Literature DB >> 34596973

Influence of omalizumab on treatment costs for chronic rhinosinusitis with nasal polyps and asthma: an insurance claims analysis.

Lauren T Roland1, Sarah K Wise2, Heqiong Wang3, Christina Mehta3, John M DelGaudio2, Joshua M Levy2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34596973      PMCID: PMC8860845          DOI: 10.1002/alr.22904

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


× No keyword cloud information.
  7 in total

1.  Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study.

Authors:  Shilpika Bajpai; Michael J Marino; Matthew A Rank; Angela M Donaldson; Erin K O'Brien; Devyani Lal
Journal:  Int Forum Allergy Rhinol       Date:  2021-02-01       Impact factor: 3.858

2.  Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.

Authors:  George A Scangas; Arthur W Wu; Jonathan Y Ting; Ralph Metson; Evan Walgama; Mark G Shrime; Thomas S Higgins
Journal:  Laryngoscope       Date:  2020-04-03       Impact factor: 3.325

Review 3.  Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: To biologic or not to biologic?

Authors:  William C Anderson; Stanley J Szefler
Journal:  Ann Allergy Asthma Immunol       Date:  2019-01-28       Impact factor: 6.347

4.  Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.

Authors:  Claus Bachert; Joseph K Han; Martin Desrosiers; Peter W Hellings; Nikhil Amin; Stella E Lee; Joaquim Mullol; Leon S Greos; John V Bosso; Tanya M Laidlaw; Anders U Cervin; Jorge F Maspero; Claire Hopkins; Heidi Olze; G Walter Canonica; Pierluigi Paggiaro; Seong H Cho; Wytske J Fokkens; Shigeharu Fujieda; Mei Zhang; Xin Lu; Chunpeng Fan; Steven Draikiwicz; Siddhesh A Kamat; Asif Khan; Gianluca Pirozzi; Naimish Patel; Neil M H Graham; Marcella Ruddy; Heribert Staudinger; David Weinreich; Neil Stahl; George D Yancopoulos; Leda P Mannent
Journal:  Lancet       Date:  2019-09-19       Impact factor: 79.321

5.  Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model.

Authors:  Ann C Wu; A David Paltiel; Karen M Kuntz; Scott T Weiss; Anne L Fuhlbrigge
Journal:  J Allergy Clin Immunol       Date:  2007-09-29       Impact factor: 10.793

Review 6.  International consensus statement on allergy and rhinology: rhinosinusitis 2021.

Authors:  Richard R Orlandi; Todd T Kingdom; Timothy L Smith; Benjamin Bleier; Adam DeConde; Amber U Luong; David M Poetker; Zachary Soler; Kevin C Welch; Sarah K Wise; Nithin Adappa; Jeremiah A Alt; Wilma Terezinha Anselmo-Lima; Claus Bachert; Fuad M Baroody; Pete S Batra; Manuel Bernal-Sprekelsen; Daniel Beswick; Neil Bhattacharyya; Rakesh K Chandra; Eugene H Chang; Alexander Chiu; Naweed Chowdhury; Martin J Citardi; Noam A Cohen; David B Conley; John DelGaudio; Martin Desrosiers; Richard Douglas; Jean Anderson Eloy; Wytske J Fokkens; Stacey T Gray; David A Gudis; Daniel L Hamilos; Joseph K Han; Richard Harvey; Peter Hellings; Eric H Holbrook; Claire Hopkins; Peter Hwang; Amin R Javer; Rong-San Jiang; David Kennedy; Robert Kern; Tanya Laidlaw; Devyani Lal; Andrew Lane; Heung-Man Lee; Jivianne T Lee; Joshua M Levy; Sandra Y Lin; Valerie Lund; Kevin C McMains; Ralph Metson; Joaquim Mullol; Robert Naclerio; Gretchen Oakley; Nobuyoshi Otori; James N Palmer; Sanjay R Parikh; Desiderio Passali; Zara Patel; Anju Peters; Carl Philpott; Alkis J Psaltis; Vijay R Ramakrishnan; Murugappan Ramanathan; Hwan-Jung Roh; Luke Rudmik; Raymond Sacks; Rodney J Schlosser; Ahmad R Sedaghat; Brent A Senior; Raj Sindwani; Kristine Smith; Kornkiat Snidvongs; Michael Stewart; Jeffrey D Suh; Bruce K Tan; Justin H Turner; Cornelis M van Drunen; Richard Voegels; De Yun Wang; Bradford A Woodworth; Peter-John Wormald; Erin D Wright; Carol Yan; Luo Zhang; Bing Zhou
Journal:  Int Forum Allergy Rhinol       Date:  2021-03       Impact factor: 5.426

7.  Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps.

Authors:  Neil Bhattacharyya; Sara Villeneuve; Vijay N Joish; Caroline Amand; Leda Mannent; Nikhil Amin; Paul Rowe; Jaman Maroni; Laurent Eckert; Tony Yang; Asif Khan
Journal:  Laryngoscope       Date:  2019-02-05       Impact factor: 3.325

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.